Development of the radiopharmaceuticals for interventional tumor therapy in China
Description
Shortly after the radioactive radium wa discovered, it made people to try using radio action of Ra in medical therapy of human's diseases. But in the past 60 year, the most interests were concentrated in clinical diagnostic techniques of nuclides. Up to date, nuclear and non-nuclear diagnostic techniques of the tumor are quite advanced, the therapeutic application of 90Y, 226Ra, 198Au and 32P nuclides have lasted for long time, several decades later, the studies of tumor interventional radiotherapeutic agents are being interested again and made a very great progresses with the development of nuclear instrument. In our institute, we are developing some very important radiotherapeutic agents in vivo for the treatment of bone metastases, hepatic cancer, brain tumor, rheumatic arthritis radioactive synovectomy,pheochromocytoma, neuroblastoma and so on. (author). 17 refs., 1 fig., 7 tabs
Additional details
Publishing Information
- Journal Title
- Journal of Radioanalytical and Nuclear Chemistry
- Journal Volume
- 206
- Journal Issue
- 1
- Journal Page Range
- p. 17-27.
- ISSN
- 0236-5731
- CODEN
- JRNCDM
Conference
- Title
- International Conference on Isotopes.
- Dates
- 7-12 May 1995.
- Place
- Beijing (China).
INIS
- Country of Publication
- Hungary
- Country of Input or Organization
- Hungary
- INIS RN
- 27075030
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Resource subtype / Literary indicator
- Conference
- Descriptors DEI
- ALPHA DECAY RADIOISOTOPES; BETA DECAY RADIOISOTOPES; CHINA; IN VIVO; RADIOPHARMACEUTICALS; RADIOTHERAPY; RESEARCH PROGRAMS
- Descriptors DEC
- ASIA; DRUGS; ISOTOPES; LABELLED COMPOUNDS; MATERIALS; MEDICINE; RADIOACTIVE MATERIALS; RADIOISOTOPES; THERAPY